Applicant |
Tradename |
Generic Name |
Dosage |
NDA |
Approval Date |
TE |
Type |
RLD |
RS |
Patent No. |
Patent Expiration |
Product |
Substance |
Delist Req. |
Patented / Exclusive Use |
Patent Submitted |
Astrazeneca Pharms |
ALVESCO |
ciclesonide |
AEROSOL, METERED;INHALATION |
021658-002 |
Jan 10, 2008 |
|
RX |
Yes |
Yes |
➤ Sign Up |
➤ Sign Up |
|
|
|
MAINTENANCE TREATMENT OF ASTHMA AS PROPHYLACTIC THERAPY IN ADULT AND ADOLESCENT PATIENTS 12 YEARS OF AGE AND OLDER. PATENT CLAIMS METHOD FOR TREATING A RESPIRATORY DISEASE IN A CHILD |
➤ Sign Up |
Astrazeneca Pharms |
ALVESCO |
ciclesonide |
AEROSOL, METERED;INHALATION |
021658-003 |
Jan 10, 2008 |
|
RX |
Yes |
Yes |
➤ Sign Up |
➤ Sign Up |
|
|
|
MAINTENANCE TREATMENT OF ASTHMA AS PROPHYLACTIC THERAPY IN ADULT AND ADOLESCENT PATIENTS 12 YEARS OF AGE AND OLDER. PATENT CLAIMS METHOD FOR TREATING A RESPIRATORY DISEASE IN A CHILD |
➤ Sign Up |
Astrazeneca Pharms |
ZETONNA |
ciclesonide |
AEROSOL, METERED;NASAL |
202129-001 |
Jan 20, 2012 |
|
RX |
Yes |
Yes |
➤ Sign Up |
➤ Sign Up |
|
|
|
TREATMENT OF SYMPTOMS ASSOCIATED WITH SEASONAL AND PERENNIAL ALLERGIC RHINITIS IN ADULTS AND ADOLESCENTS 12 YEARS OF AGE AND OLDER. PATENT CLAIMS METHODS FOR TREATING A RESPIRATORY DISEASE IN A CHILD |
➤ Sign Up |
Astrazeneca Pharms |
OMNARIS |
ciclesonide |
SPRAY, METERED;NASAL |
022004-001 |
Oct 20, 2006 |
|
RX |
Yes |
Yes |
➤ Sign Up |
➤ Sign Up |
|
|
|
TREATMENT OF NASAL SYMPTOMS ASSOCIATED WITH SEASONAL ALLERGIC RHINITIS IN ADULTS AND CHILDREN 6 YEARS OF AGE AND OLDER. TREATMENT OF NASAL SYMPTOMS ASSOCIATED W PERENNIAL ALLERGIC RHINITIS IN ADULTS AND ADOLESCENTS 12 YEARS OF AGE AND OLDER |
➤ Sign Up |
Applicant |
Tradename |
Generic Name |
Dosage |
NDA |
Approval Date |
TE |
Type |
RLD |
RS |
Patent No. |
Patent Expiration |
Product |
Substance |
Delist Req. |
Patented / Exclusive Use |
Patent Submitted |
This preview shows a limited data set. Subscribe for full access, or try a Free Trial